What is Viveve?
Founded in 2005 and based in Englewood, Colorado, Viveve Medical, Inc. is dedicated to advancing women's intimate health through cutting-edge medical technology. The company designs and manufactures non-invasive treatment solutions aimed at addressing various conditions that impact women's quality of life. By merging deep medical expertise with technological innovation, Viveve seeks to fill critical unmet needs within the women's healthcare sector, offering improved patient outcomes through its specialized product portfolio.
How much funding has Viveve raised?
Viveve has raised a total of $210.8M across 21 funding rounds:
Debt
$500K
Share Placement
$6M
Share Placement
$12M
Share Placement
$6M
Stock Offering
$15.5M
Debt
$10M
Stock Offering
$31.7M
Debt
$30M
Stock Offering
$32.4M
Stock Offering
$18.8M
Stock Offering
$6.8M
Stock Offering
$11.5M
Multiple Rounds
$7.6M
Debt (2014): $500K, investors not publicly disclosed
Share Placement (2014): $6M supported by GBS Venture Partners, 5AM Ventures, and Alta BioEquities
Share Placement (2015): $12M featuring Stonepine Capital, 5AM Ventures, and Alta Bioequities
Share Placement (2015): $6M backed by RTW Investments, Manchester Management Company, Wexford Capital LP, Stonepine Capital, and Alta Bioequities
Stock Issuance/Offering (2016): $15.5M, investors not publicly disclosed
Debt (2016): $10M led by Bridge Bank
Stock Issuance/Offering (2017): $31.7M, investors not publicly disclosed
Debt (2017): $30M featuring CRG LP
Stock Issuance/Offering (2018): $32.4M, investors not publicly disclosed
Stock Issuance/Offering (2018): $18.8M, investors not publicly disclosed
Stock Issuance/Offering (2019): $6.8M, investors not publicly disclosed
Stock Issuance/Offering (2019): $11.5M, investors not publicly disclosed
Debt (2020): $1M featuring PPP
Other Financing Round (2020): $3M, investors not publicly disclosed
Other Financing Round (2020): $3.6M, investors not publicly disclosed
Key Investors in Viveve
GBS Venture Partners
GBS Venture Partners is a venture capital firm specializing in life sciences, investing in early-stage companies with the potential for significant impact and financial returns. They have a long history of supporting biotech and medtech innovators.
5AM Ventures
5AM Ventures is a venture capital firm with a strong focus on the life sciences sector, backing early-stage biotech and healthcare innovators. They partner closely with founders to advance scientific breakthroughs.
Bridge Bank
Bridge Bank is a financial institution that provides banking services, including debt financing, to various industries, likely supporting Viveve's operational and growth needs through its lending solutions.
What's next for Viveve?
The recent major strategic investment indicates Viveve is poised for significant scaling and market expansion. This capital injection will likely fuel further research and development, enhance manufacturing capabilities, and support broader commercialization efforts. As a company in a significant growth phase, Viveve is expected to leverage this funding to solidify its market position and introduce its advanced women's health solutions to a wider audience, potentially exploring new therapeutic areas or geographical markets.
See full Viveve company page
